Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)
- 15 May 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (10), 1146-1152
- https://doi.org/10.1016/j.amjcard.2005.01.040
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)The Lancet, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- A Paclitaxel-Eluting Stent for the Prevention of Coronary RestenosisNew England Journal of Medicine, 2003
- TAXUS ICirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Explaining heterogeneity in meta-analysis: a comparison of methodsStatistics in Medicine, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981